Evaluate post-clearance device changes consistently, determine when existing clearance remains supportable, and document the regulatory rationale behind decisions to submit — or not submit — a new 510(k).
Includes live access & recording
Changes to a 510(k)-cleared medical device can arise from design improvements, component substitutions, labeling revisions, manufacturing changes, software updates, risk controls, or responses to field experience. Each change requires an assessment of whether it could significantly affect the device's safety or effectiveness, or whether it represents a major change or modification in intended use. The decision determines whether the change can proceed under the existing clearance or requires submission and clearance of a new 510(k).
This course focuses on the practical evaluation of post-clearance device changes using FDA's risk-based approach to 510(k) change assessment. It addresses how intended use, labeling, technology, performance, materials, manufacturing, and software-related changes influence the submission decision; how multiple related changes should be considered together; and how risk analysis and supporting testing inform the conclusion.
Particular attention is given to documenting decisions when a new 510(k) is determined not to be required.
Develop a structured basis for assessing whether changes to intended use, labeling, technology, materials, manufacturing, performance, or software could cross the threshold for a new 510(k). This helps regulatory, quality, and engineering teams reach consistent conclusions before implementation rather than attempting to justify the regulatory pathway after changes have already occurred.
Strengthen the Evidence Behind No-New-510(k) Conclusions. Learn how risk assessment, testing, design-control evidence, and documented reasoning support decisions that a modification can remain under an existing clearance. When several changes accumulate or interact, a clear assessment of their collective impact becomes particularly important for demonstrating why the marketed device remains appropriately covered by its existing 510(k).
By the end of this session, participants will be equipped to evaluate post-clearance changes and document the regulatory rationale behind the submission decision.
Apply FDA decision principles for determining when a device modification requires a new 510(k).
Evaluate changes to intended use, indications, labeling, and conditions of use.
Assess technology, engineering, materials, performance, and manufacturing modifications.
Determine the regulatory impact of software and firmware changes.
Apply risk-based assessment to changes that may affect device safety or effectiveness.
Evaluate multiple related or cumulative modifications together rather than in isolation.
Use testing, risk analysis, and design-control evidence to support the submission decision.
Document the rationale when a new 510(k) is determined not to be required.
Focused areas that will strengthen how your organization evaluates and documents post-clearance device changes.
Apply FDA's risk-based framework for determining when a device modification could significantly affect safety or effectiveness, or change intended use.
Evaluate changes to intended use, indications, labeling, and conditions of use that may cross the threshold for a new submission.
Determine the regulatory impact of software and firmware modifications on the existing clearance.
Use testing, risk analysis, and design-control evidence to document why a modification remains under the existing clearance.
A comprehensive look at how post-clearance changes are evaluated against FDA's risk-based approach to 510(k) change assessment.
Professionals across regulatory, quality, and engineering functions responsible for evaluating changes to cleared medical devices.
Regulatory Affairs Departments
Quality Assurance Departments
Design Engineering
Product Development / R&D Departments
Design Quality / Quality Engineering
Regulatory Compliance Departments
Risk Management
Software / Firmware Engineering
Manufacturing Engineering
Medical Device Quality Systems
Changes to a 510(k)-cleared medical device can arise from design improvements, component substitutions, labeling revisions, manufacturing changes, software updates, risk controls, or responses to field experience. Each change requires an assessment of whether it could significantly affect the device's safety or effectiveness, or whether it represents a major change or modification in intended use.
FDA's risk-based approach to 510(k) change assessment addresses how intended use, labeling, technology, performance, materials, manufacturing, and software-related changes influence the submission decision, and how multiple related changes should be considered together rather than in isolation. Risk analysis and supporting testing inform the conclusion of whether a change can proceed under the existing clearance or requires a new 510(k).
This course strengthens the ability to evaluate post-clearance device changes consistently, determine when existing clearance remains supportable, and document the regulatory rationale behind decisions to submit or not submit a new 510(k) — with particular attention to documenting decisions when a new 510(k) is determined not to be required.
Don't miss this essential training on evaluating post-clearance device changes and documenting when a new 510(k) is required. Secure your spot now.